XPH: Healthcare Dashboard For July

Healthcare sector valuation update: pharma/biotech near 11-year baselines, equipment undervalued. Click for more on State Street SPDR S&P Pharmaceuticals ETF

This monthly article series provides a top-down analysis of the healthcare sector, based on value, quality, and momentum metrics. It may also help analyze ETFs like the State Street Health Care Select Sector SPDR ETF ( Summary - Pharmaceuticals/biotechnology valuations and quality are near 11-year historical baselines, while healthcare equipment appears undervalued and life science tools least attractive. - State Street SPDR S&P Pharmaceuticals ETF offers diversified pharmaceutical exposure with a modified equal-weight strategy, reducing company-specific risk versus capital-weighted peers.

- XPH is best suited for swing trading or tactical allocation, as the long-term risk-return profile is uncompelling. - 10 healthcare stocks are cheaper than their peers in July. - Quantitative Risk & Value members get exclusive access to our real-world portfolio.

See all our investments here » Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha).

I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor.

Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party